Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats

The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental hypertension (1993) 1991, Vol.A13 (2), p.219-234
Hauptverfasser: Secrest, Roberta J., Williams, Patricia, Bonjouklian, Rosanne, Modlin, Deah, Firman, Kenneth, Turk, John, Cohen, Marlene L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 234
container_issue 2
container_start_page 219
container_title Clinical and experimental hypertension (1993)
container_volume A13
creator Secrest, Roberta J.
Williams, Patricia
Bonjouklian, Rosanne
Modlin, Deah
Firman, Kenneth
Turk, John
Cohen, Marlene L.
description The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone.
doi_str_mv 10.3109/10641969109042060
format Article
fullrecord <record><control><sourceid>informahealthcare_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_19840342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_10641969109042060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</originalsourceid><addsrcrecordid>eNp9UMtKxDAUDaL4_gAXQjburCZtGht0I-ILRcXRdbmT3jKRTlKSjDJ-vdEZFRFmdQ_3PHJzCNnh7KDgTB1yJgVXUiXMRM4kWyLrvMzLTDImlxNOfJYExRrZCOGFMS5kWa2S1aQtE1wn71fT3kW0wbwiffCuRx8NBupaGkdfm4jG0htjISC9tiMzNNH5fTqIMPEu9M4bi_s0ae6cH_9EgW3ooHc2gkU3Cd2UpodS9px-hBi2yEoLXcDt-dwkzxfnT2dX2e395fXZ6W2mhWQxa4FXoJu8alDpSkloiqHIVamRKcUV8FKXR0JLgcC1aIaq1byEthBcaJ0jKzYJn-XqdG_w2Na9N2Pw05qz-rPG-l-NybM78_ST4RibH8e8t8TvzXkIGrrWg9Um_AarSrBC5El3MtMZ26Z64M35rqkjTDvnv03FojOO_9hHCF0cafBYv7iJt6m2BZ_4AANQorA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</title><source>MEDLINE</source><source>Taylor &amp; Francis Journals Complete</source><creator>Secrest, Roberta J. ; Williams, Patricia ; Bonjouklian, Rosanne ; Modlin, Deah ; Firman, Kenneth ; Turk, John ; Cohen, Marlene L.</creator><creatorcontrib>Secrest, Roberta J. ; Williams, Patricia ; Bonjouklian, Rosanne ; Modlin, Deah ; Firman, Kenneth ; Turk, John ; Cohen, Marlene L.</creatorcontrib><description>The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone.</description><identifier>ISSN: 1064-1963</identifier><identifier>ISSN: 0730-0077</identifier><identifier>EISSN: 1525-6006</identifier><identifier>DOI: 10.3109/10641969109042060</identifier><identifier>PMID: 2065465</identifier><identifier>CODEN: CEHADM</identifier><language>eng</language><publisher>Basel: Informa UK Ltd</publisher><subject>Alkaloids - pharmacology ; Animals ; Aorta ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Pressure ; Blood Pressure - drug effects ; Cardiology. Vascular system ; Decerebrate State ; Experimental diseases ; Heart Rate ; Heart Rate - drug effects ; Hemodynamics - drug effects ; Hypotension - chemically induced ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; Protein Kinase Inhibitors ; Rat ; Rats ; Rats, Inbred SHR - physiology ; Rats, Inbred Strains ; Reference Values ; Serotonin - pharmacology ; Staurosporine ; Vasoconstriction - drug effects</subject><ispartof>Clinical and experimental hypertension (1993), 1991, Vol.A13 (2), p.219-234</ispartof><rights>1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1991</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</citedby><cites>FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/10641969109042060$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/10641969109042060$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,4009,27902,27903,27904,59624,60413,61198,61379</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19840342$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2065465$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Secrest, Roberta J.</creatorcontrib><creatorcontrib>Williams, Patricia</creatorcontrib><creatorcontrib>Bonjouklian, Rosanne</creatorcontrib><creatorcontrib>Modlin, Deah</creatorcontrib><creatorcontrib>Firman, Kenneth</creatorcontrib><creatorcontrib>Turk, John</creatorcontrib><creatorcontrib>Cohen, Marlene L.</creatorcontrib><title>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</title><title>Clinical and experimental hypertension (1993)</title><addtitle>Clin Exp Hypertens A</addtitle><description>The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone.</description><subject>Alkaloids - pharmacology</subject><subject>Animals</subject><subject>Aorta</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiology. Vascular system</subject><subject>Decerebrate State</subject><subject>Experimental diseases</subject><subject>Heart Rate</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>Hypotension - chemically induced</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Protein Kinase Inhibitors</subject><subject>Rat</subject><subject>Rats</subject><subject>Rats, Inbred SHR - physiology</subject><subject>Rats, Inbred Strains</subject><subject>Reference Values</subject><subject>Serotonin - pharmacology</subject><subject>Staurosporine</subject><subject>Vasoconstriction - drug effects</subject><issn>1064-1963</issn><issn>0730-0077</issn><issn>1525-6006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UMtKxDAUDaL4_gAXQjburCZtGht0I-ILRcXRdbmT3jKRTlKSjDJ-vdEZFRFmdQ_3PHJzCNnh7KDgTB1yJgVXUiXMRM4kWyLrvMzLTDImlxNOfJYExRrZCOGFMS5kWa2S1aQtE1wn71fT3kW0wbwiffCuRx8NBupaGkdfm4jG0htjISC9tiMzNNH5fTqIMPEu9M4bi_s0ae6cH_9EgW3ooHc2gkU3Cd2UpodS9px-hBi2yEoLXcDt-dwkzxfnT2dX2e395fXZ6W2mhWQxa4FXoJu8alDpSkloiqHIVamRKcUV8FKXR0JLgcC1aIaq1byEthBcaJ0jKzYJn-XqdG_w2Na9N2Pw05qz-rPG-l-NybM78_ST4RibH8e8t8TvzXkIGrrWg9Um_AarSrBC5El3MtMZ26Z64M35rqkjTDvnv03FojOO_9hHCF0cafBYv7iJt6m2BZ_4AANQorA</recordid><startdate>1991</startdate><enddate>1991</enddate><creator>Secrest, Roberta J.</creator><creator>Williams, Patricia</creator><creator>Bonjouklian, Rosanne</creator><creator>Modlin, Deah</creator><creator>Firman, Kenneth</creator><creator>Turk, John</creator><creator>Cohen, Marlene L.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Dekker</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1991</creationdate><title>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</title><author>Secrest, Roberta J. ; Williams, Patricia ; Bonjouklian, Rosanne ; Modlin, Deah ; Firman, Kenneth ; Turk, John ; Cohen, Marlene L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-fa18acd28de9c896ad3b4295ce09919a15c574c64ea1c4db9fc15af3414cc2e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Alkaloids - pharmacology</topic><topic>Animals</topic><topic>Aorta</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiology. Vascular system</topic><topic>Decerebrate State</topic><topic>Experimental diseases</topic><topic>Heart Rate</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>Hypotension - chemically induced</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Protein Kinase Inhibitors</topic><topic>Rat</topic><topic>Rats</topic><topic>Rats, Inbred SHR - physiology</topic><topic>Rats, Inbred Strains</topic><topic>Reference Values</topic><topic>Serotonin - pharmacology</topic><topic>Staurosporine</topic><topic>Vasoconstriction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Secrest, Roberta J.</creatorcontrib><creatorcontrib>Williams, Patricia</creatorcontrib><creatorcontrib>Bonjouklian, Rosanne</creatorcontrib><creatorcontrib>Modlin, Deah</creatorcontrib><creatorcontrib>Firman, Kenneth</creatorcontrib><creatorcontrib>Turk, John</creatorcontrib><creatorcontrib>Cohen, Marlene L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical and experimental hypertension (1993)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Secrest, Roberta J.</au><au>Williams, Patricia</au><au>Bonjouklian, Rosanne</au><au>Modlin, Deah</au><au>Firman, Kenneth</au><au>Turk, John</au><au>Cohen, Marlene L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats</atitle><jtitle>Clinical and experimental hypertension (1993)</jtitle><addtitle>Clin Exp Hypertens A</addtitle><date>1991</date><risdate>1991</risdate><volume>A13</volume><issue>2</issue><spage>219</spage><epage>234</epage><pages>219-234</pages><issn>1064-1963</issn><issn>0730-0077</issn><eissn>1525-6006</eissn><coden>CEHADM</coden><abstract>The protein kinase inhibitor, staurosporine, was examined for hemodynamic actions in conscious rats and for its effects on isolated vascular smooth muscle. In conscious normotensive rats, staurosporine, 0.1 to 1.0 mg/kg intravenous, produced a dose-related decrease in blood pressure. Doses of 0.1 and 0.5 mg/kg produced reflex tachycardia, while heart rate decreased following 1.0 mg/kg. Higher doses of staurosporine (5 and 10 mg/kg), although not significantly altering heart rate, caused a precipitous drop in blood pressure and all rats died within 48 hours of treatment. Spontaneously hypertensive rats were significantly more sensitive than normotensive rats to the blood pressure lowering effects of staurosporine. The depressor activity of staurosporine was also observed in cord-stimulated pithed rats indicating that hypotension is a peripherally-rather than centrally-mediated effect of staurosporine. In ring preparations of rat thoracic aorta, staurosporine (3 nM to 0.1 mM) produced a concentration-dependent inhibition of serotonin-induced contraction, consistent with its ability to lower blood pressure by an effect at a peripheral vascular site. These results provide the first documentation of the potent cardiovascular activity of staurosporine in the conscious rat and support the contention that protein kinases, in particular protein kinase C, may be important in the regulation of vascular tone.</abstract><cop>Basel</cop><cop>Hong Kong</cop><cop>New York, NY</cop><pub>Informa UK Ltd</pub><pmid>2065465</pmid><doi>10.3109/10641969109042060</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1064-1963
ispartof Clinical and experimental hypertension (1993), 1991, Vol.A13 (2), p.219-234
issn 1064-1963
0730-0077
1525-6006
language eng
recordid cdi_pascalfrancis_primary_19840342
source MEDLINE; Taylor & Francis Journals Complete
subjects Alkaloids - pharmacology
Animals
Aorta
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Blood Pressure
Blood Pressure - drug effects
Cardiology. Vascular system
Decerebrate State
Experimental diseases
Heart Rate
Heart Rate - drug effects
Hemodynamics - drug effects
Hypotension - chemically induced
Medical sciences
Muscle, Smooth, Vascular - drug effects
Protein Kinase Inhibitors
Rat
Rats
Rats, Inbred SHR - physiology
Rats, Inbred Strains
Reference Values
Serotonin - pharmacology
Staurosporine
Vasoconstriction - drug effects
title Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T07%3A48%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypotensive%20Properties%20of%20the%20Protein%20Kinase%20Inhibitor,%20Staurosporine,%20in%20Normotensive%20and%20Spontaneously%20Hypertensive%20Rats&rft.jtitle=Clinical%20and%20experimental%20hypertension%20(1993)&rft.au=Secrest,%20Roberta%20J.&rft.date=1991&rft.volume=A13&rft.issue=2&rft.spage=219&rft.epage=234&rft.pages=219-234&rft.issn=1064-1963&rft.eissn=1525-6006&rft.coden=CEHADM&rft_id=info:doi/10.3109/10641969109042060&rft_dat=%3Cinformahealthcare_pasca%3E10_3109_10641969109042060%3C/informahealthcare_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2065465&rfr_iscdi=true